Farhad Jadidi‐Niaragh

43.4k total citations · 1 hit paper
211 papers, 8.3k citations indexed

About

Farhad Jadidi‐Niaragh is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Farhad Jadidi‐Niaragh has authored 211 papers receiving a total of 8.3k indexed citations (citations by other indexed papers that have themselves been cited), including 109 papers in Immunology, 79 papers in Molecular Biology and 56 papers in Oncology. Recurrent topics in Farhad Jadidi‐Niaragh's work include Immune Cell Function and Interaction (39 papers), Immunotherapy and Immune Responses (33 papers) and RNA Interference and Gene Delivery (27 papers). Farhad Jadidi‐Niaragh is often cited by papers focused on Immune Cell Function and Interaction (39 papers), Immunotherapy and Immune Responses (33 papers) and RNA Interference and Gene Delivery (27 papers). Farhad Jadidi‐Niaragh collaborates with scholars based in Iran, Sweden and Russia. Farhad Jadidi‐Niaragh's co-authors include Mehdi Yousefi, Abbas Mirshafiey, Ghasem Ghalamfarsa, Gholamreza Azizi, Mohammad Hojjat‐Farsangi, Hamed Mohammadi, Majid Ahmadi, Ali Masjedi, Leili Aghebati‐Maleki and Enayat Anvari and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Controlled Release.

In The Last Decade

Farhad Jadidi‐Niaragh

198 papers receiving 8.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nanoparticles and targeted drug delivery in cancer therapy

2017 380 citations Mohammad Hojjat‐Farsangi, Hamed Mohammadi et al. Immunology Letters profile →

Peers

Countries citing papers authored by Farhad Jadidi‐Niaragh

Since Specialization

Citations

This map shows the geographic impact of Farhad Jadidi‐Niaragh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Farhad Jadidi‐Niaragh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Farhad Jadidi‐Niaragh more than expected).

Fields of papers citing papers by Farhad Jadidi‐Niaragh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Farhad Jadidi‐Niaragh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Farhad Jadidi‐Niaragh. The network helps show where Farhad Jadidi‐Niaragh may publish in the future.

Co-authorship network of co-authors of Farhad Jadidi‐Niaragh

This figure shows the co-authorship network connecting the top 25 collaborators of Farhad Jadidi‐Niaragh. A scholar is included among the top collaborators of Farhad Jadidi‐Niaragh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Farhad Jadidi‐Niaragh. Farhad Jadidi‐Niaragh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Safety and Efficacy of Anti-LAG-3 for Patients with Melanoma: A Systematic Review and Meta-analysis Study 2025 ·Anti-Cancer Agents in Medicinal Chemistry ·(unknown), (unknown), (unknown), Mohsen Dashti, Ali Daryabeigi Zand, (unknown), (unknown), (unknown), (unknown), (unknown), Mohammad Amin Habibi, (unknown), Farhad Jadidi‐Niaragh	0
2	Boosting immunotherapy efficacy: Empowering the Potency of Dendritic cells loaded with breast cancer lysates through CTLA-4 suppression 2024 ·Heliyon ·(unknown), Javad Masoumi, Farid Ghorbaninezhad, Leili Aghebati‐Maleki, (unknown), Siamak Sandoghchian Shotorbani, Farhad Jadidi‐Niaragh, Amir Baghbanzadeh, Nima Hemmat, Elham Baghbani, Amir Ghaffari Jolfayi, Behzad Baradaran	2
3	Blockade of CD155 and Interleukin-6 Suppresses Breast Cancer Cell Growth 2023 ·(unknown), (unknown), Hadi Hassannia, (unknown), (unknown), Vida Hashemi, Mohammad Hojjat‐Farsangi, Farhad Jadidi‐Niaragh	0
4	Pan Cyclin-Dependent Kinase Inhibitors for the Treatment of Breast Cancer 2023 ·Sepideh Izadi, (unknown), Vahid Karpisheh, Farhad Jadidi‐Niaragh	0
5	Association of the genetic variants in the endoplasmic reticulum aminopeptidase 2 gene with ankylosing spondylitis susceptibility 2021 ·International Journal of Rheumatic Diseases ·(unknown), Fatemeh Ezzatifar, Shahram Torkamandi, Fatemeh Mohammadi, (unknown), Arezoo Gowhari Shabgah, Maryam Hemmatzadeh, Saeed Aslani, Farhad Babaie, Farhad Jadidi‐Niaragh, Jamshid Gholizadeh Navashenaq, Hamed Mohammadi	1
6	Different T cell related immunological profiles in COVID-19 patients compared to healthy controls 2021 ·International Immunopharmacology ·(unknown), Vahid Karpisheh, Balsam Qubais Saeed, Angelina Olegovna Zekiy, (unknown), Mohsen Nabi‐Afjadi, (unknown), (unknown), (unknown), (unknown), Navneet Joshi, Kazem Abbaszadeh‐Goudarzi, Shahin Hallaj, Majid Ahmadi, Sanam Dolati, Ata Mahmoodpoor, Vida Hashemi, Farhad Jadidi‐Niaragh	28
7	PD‐1/PD‐L1 blockade: Prospectives for immunotherapy in cancer and autoimmunity 2021 ·IUBMB Life ·Ramin Hosseinzadeh, (unknown), Navid Shomali, Walid Kamal Abdelbasset, Maryam Hemmatzadeh, Jamshid Gholizadeh Navashenaq, Farhad Jadidi‐Niaragh, Dmitry Olegovich Bokov, (unknown), Hamed Mohammadi	20
8	Chemical composition and cytotoxic activity of the essential oil from the aerial parts ofDorema aucheri 2021 ·Journal of Herbmed Pharmacology ·(unknown), (unknown), (unknown), Zeinab Salehpour, (unknown), (unknown), Bahram Mohammadi, Farhad Jadidi‐Niaragh, Ali Ganji, Ghasem Ghalamfarsa	2
9	Targeting Wee1 kinase as a therapeutic approach in Hematological Malignancies 2021 ·DNA repair ·(unknown), Abduladheem Turki Jalil, Walid Kamal Abdelbasset, Alexei Valerievich Yumashev, Vahid Karpisheh, (unknown), (unknown), Majid Ahmadi, (unknown), Farhad Jadidi‐Niaragh	39
10	Concomitant blockade of A2AR and CTLA‐4 by siRNA‐loaded polyethylene glycol‐chitosan‐alginate nanoparticles synergistically enhances antitumor T‐cell responses 2020 ·Journal of Cellular Physiology ·(unknown), Seyed Hossein Kiaie, (unknown), (unknown), Mohsen Nabi‐Afjadi, (unknown), (unknown), (unknown), Armin Ahmadi, Ali Masjedi, Hadi Hassannia, Fatemeh Atyabi, Mohammad Hojjat‐Farsangi, Afshin Namdar, Ghasem Ghalamfarsa, Farhad Jadidi‐Niaragh	33
11	Critical roles of long noncoding RNAs in breast cancer 2020 ·Journal of Cellular Physiology ·(unknown), Sadra Samavarchi Tehrani, Tooba Yousefi, Ansar Karimian, Ata Mahmoodpoor, (unknown), Farhad Jadidi‐Niaragh, Mehdi Yousefi, Hossein Samadi Kafil, Milad Bastami, Mahdi Edalati, Shirin Eyvazi, (unknown), Niloufar Targhazeh, Ainaz Mihanfar, Bahman Yousefi, Amin Safa, Maryam Majidinia, (unknown)	45
12	Codelivery of STAT3 siRNA and BV6 by carboxymethyl dextran trimethyl chitosan nanoparticles suppresses cancer cell progression 2020 ·International Journal of Pharmaceutics ·Afshin Nikkhoo, (unknown), (unknown), (unknown), (unknown), Fatemeh Atyabi, (unknown), (unknown), Mehdi Yousefi, (unknown), Ghasem Ghalamfarsa, Hamed Mohammadi, Mozhdeh Sojoodi, Farhad Jadidi‐Niaragh	64
13	Cyclosporine A improves pregnancy outcomes in women with recurrent pregnancy loss and elevated Th1/Th2 ratio 2019 ·Journal of Cellular Physiology ·Ramyar Azizi, Majid Ahmadi, Shahla Danaii, (unknown), (unknown), Shadi Eghbal‐Fard, Sanam Dolati, Amin Kamrani, (unknown), Amir Mehdizadeh, Farhad Jadidi‐Niaragh, Bahman Yousefi, Mehdi Yousefi	42
14	Cytokine profile, Treg/Th17 cell frequency changes during different posttransplantational time points in patients undergoing renal transplantation 2019 ·Journal of Cellular Physiology ·(unknown), Mohammad Sadegh Soltani‐Zangbar, Shadi Eghbal‐Fard, Amir Mehdizadeh, Amin Kamrani, (unknown), Hossein Samadi Kafil, Farhad Jadidi‐Niaragh, (unknown), Hamid Tayebi Khosroshahi, Mehdi Yousefi	9
15	S1PR1 as a Novel Promising Therapeutic Target in Cancer Therapy 2019 ·Molecular Diagnosis & Therapy ·(unknown), Afshin Nikkhoo, (unknown), Gholamreza Azizi, Mohammad Hojjat‐Farsangi, Ghasem Ghalamfarsa, Bahman Yousefi, Mehdi Yousefi, Farhad Jadidi‐Niaragh	47
16	MicroRNAs in breast cancer: Roles, functions, and mechanism of actions 2019 ·Journal of Cellular Physiology ·(unknown), Sadra Samavarchi Tehrani, Tooba Yousefi, Ansar Karimian, Ata Mahmoodpoor, (unknown), Farhad Jadidi‐Niaragh, Mehdi Yousefi, Hossein Samadi Kafil, Milad Bastami, Mahdi Edalati, Shirin Eyvazi, (unknown), Niloufar Targhazeh, Bahman Yousefi, Amin Safa, Maryam Majidinia, (unknown)	75
17	Polymorphism of Foxp3 gene affects the frequency of regulatory T cells and disease activity in patients with rheumatoid arthritis in Iranian population 2018 ·Immunology Letters ·Vida Hashemi, Amir Salek Farrokhi, Asghar Tanomand, Zohreh Babaloo, Mohammad Hojjat‐Farsangi, Enayat Anvari, (unknown), Rana Ezzeddini, Arezoo Hosseini, Tohid Gharibi, Ghasem Ghalamfarsa, Farhad Jadidi‐Niaragh	26
18	The significant role of interleukin-6 and its signaling pathway in the immunopathogenesis and treatment of breast cancer 2018 ·Biomedicine & Pharmacotherapy ·Ali Masjedi, Vida Hashemi, Mohammad Hojjat‐Farsangi, Ghasem Ghalamfarsa, Gholamreza Azizi, Mehdi Yousefi, Farhad Jadidi‐Niaragh	222
19	Anti‐angiogenic effects of CD73‐specific siRNA‐loaded nanoparticles in breast cancer‐bearing mice 2018 ·Journal of Cellular Physiology ·Ghasem Ghalamfarsa, Ali Rastegari, Fatemeh Atyabi, Hadi Hassannia, Mohammad Hojjat‐Farsangi, Amir Ghanbari, Enayat Anvari, Jamshid Mohammadi, Gholamreza Azizi, Ali Masjedi, Mehdi Yousefi, Bahman Yousefi, Jamshid Hadjati, Farhad Jadidi‐Niaragh	53
20	Adenosine and adenosine receptors in the immunopathogenesis and treatment of cancer 2017 ·Journal of Cellular Physiology ·Mohammad Hossein Kazemi, (unknown), Mohammad Hojjat‐Farsangi, Enayat Anvari, Ghasem Ghalamfarsa, Hamed Mohammadi, Farhad Jadidi‐Niaragh	118

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact